A total synthesis of salinosporamide A

Salinosporamide A is a β‐lactone proteasome inhibitor currently in clinical trials for the treatment of multiple‐myeloma. Herein we report a short synthesis of this small, highly functionalized, biologically important natural product that uses an oxidative radical cyclization as a key step and allo...